Michael Bigham

Shares of Paratek Pharmaceuticals Inc (NASDAQ: PRTK) soared by more than 30 percent on Wednesday after a Bloomberg report suggested the company is looking to sell itself to a larger peer. Sources close to the matter told Bloomberg that Paratek is still in the exploration phase and is consulting...